Runben Biotechnology Co (SHSE:603193) Cyclically Adjusted PS Ratio: (As of Aug. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603193 Runben Biotechnology Co Ltd SHSE:603193
71 GF Score
Price ¥20.55
GF Value ¥28.62
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Runben Biotechnology Co Cyclically Adjusted PS Ratio?

Runben Biotechnology Co does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.

Shiller PE for Stocks: The True Measure of Stock Valuation


Runben Biotechnology Co  (SHSE:603193) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Runben Biotechnology Co Cyclically Adjusted PS Ratio Related Terms


Runben Biotechnology Co Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Runben Biotechnology Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Runben Biotechnology Co Cyclically Adjusted PS Ratio Chart

Runben Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Runben Biotechnology Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SHSE:603193 vs PG, CL, KVUE: Cyclically Adjusted PS Ratio Comparison

For the Household & Personal Products subindustry, Runben Biotechnology Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Runben Biotechnology Co Cyclically Adjusted PS Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Runben Biotechnology Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Runben Biotechnology Co's Cyclically Adjusted PS Ratio falls into.


SHSE:603193
71GF Score
Runben Biotechnology Co Ltd SHSE:603193
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Runben Biotechnology Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Runben Biotechnology Co does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.

Is Runben Biotechnology Co (SHSE:603193) Overvalued in 2026?

Based on GuruFocus' analysis, Runben Biotechnology Co stock appears to be undervalued. The current stock price of ¥20.55 is trading 28.2% below its estimated GF Value™ of ¥28.62. GuruFocus considers Runben Biotechnology Co to be Modestly Undervalued.

Key valuation signals for SHSE:603193:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ¥28.62 vs. price of ¥20.55 (28.2% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the SHSE:603193 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Runben Biotechnology Co Business Description

Address No. 3, Xinzhuang 5th Road, Guangzhou Economic and Technological Development Zone, Guangdong, Guangzhou, CHN, 510627
Runben Biotechnology Co Ltd is engaged in research & development, production and sales of mosquito repellent and personal care products.
71GF Score

Get the complete analysis for SHSE:603193

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥20.55
Price
¥28.62
GF Value